Skip to main content
. 2022 Jul 1;48(3):e20210367. doi: 10.36416/1806-3756/e20210367

Table 4. Patient-reported outcomes for the sample as a whole and for the eosinophilic phenotype.

Variable Total Blood eosinophil count > 300 cells/mm3 Blood eosinophil count of ≤ 300 cells/mm3 p
(N = 385) (n = 154) (n = 231)
SGRQ
Symptoms score (%)
Median (IQR) 55.6 (39.3-71.9) 54.3 (40.2-75.2) 57.6 (38.2-70.1) 0.4658*
Activity score (%)
Median (IQR) 60.8 (49.2-74.6) 60.4 (47.7-73.6) 61.1 (53.2-79.2) 0.2691*
Impact score (%)
Median (IQR) 39.9 (23.3-55.6) 38.8 (21.6-54.0) 42.2 (24.2-58.3) 0.1320*
Total score (%)
Median (IQR) 49.8 (35.3-63.1) 48.8 (34.6-61.0) 50.4 (35.8-65.4) 0.2405
ACQ-5
Total score
Median (IQR) 2.0 (1.0-2.8) 1.8 (1.0-2.8) 2.2 (1.0-3.0) 0.3290*
ACQ-5 categories, n (%)
Well-controlled 141 (36.6) 59 (38.3) 82 (35.5) 0.5745††
Uncontrolled 244 (63.4) 95 (61.7) 149 (64.5)

SGRQ: Saint George’s Respiratory Questionnaire; and ACQ-5: 5-item Asthma Control Questionnaire. *Mann-Whitney test. Student’s t-test. ††Chi-square test.